Quick context
KPV
Se estudia preclínicamente en relación con inflamación, piel y reparación de heridas.
No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.
Back to all 64 profiles
Community/research information onlyNo aprobado por FDA/EMA
Community protocol · KPV
KPV: community information and evidence, clearly separated.
A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.
Also known as: Lys-Pro-Val · α-MSH fragment
Sources checked: 27 August 2026
Aviso importante de seguridad y responsabilidad
Esta página documenta y evalúa información de comunidades. No es consejo médico ni terapéutico, asesoramiento individual ni invitación al uso.
No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.
Amounts, timing and cycles
Community/research information only
No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.
Amount status
Different amounts circulate online; no regulator-confirmed safe or effective dose exists.
Profile evidence level: preclinical.
Timing
Community claims about time of day, fasting windows or training intervals are not validated clinical standards.
No individual recommendation.
Cycle/duration
Cycles and breaks are community constructs and do not prevent adverse effects or unknown long-term consequences.
No individual recommendation.
External community reference available
The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.
Open community sourceReconstitución y conversión U-100
Calculadora de reconstitución
For clearly identified single lyophilised substances, the calculator only shows the arithmetic between vial amount, liquid volume and target amount. It does not check identity, purity, sterility, solubility, stability or solvent suitability. The entered target is not a recommendation.
Calculadora de reconstitución
Calculates concentration, volume and theoretical U-100 units. The preloaded 200 µg is only the reference page's arithmetic example.
Concentration
3,333.33 µg/ml
Calculated volume
0.06 ml
U-100 units
6 U
Calculated portions per vial
50
Calculation aid, not dosage or use advice. Incorrect inputs, a different syringe scale, measurement error, dead space or unknown vial content produce incorrect results.
Mechanism and research questions
Alpha-MSH-derived tripeptide
KPV is classified as “Alpha-MSH-derived tripeptide”. Se estudia preclínicamente en relación con inflamación, piel y reparación de heridas. This describes the investigated pathway but does not validate a community use, amount, route or combination.
Fragmento de tripéptido
Esto examina la función de un bloque de construcción muy corto compuesto por solo tres aminoácidos, comparable a una palabra muy corta dentro de una frase larga. Normalmente se mide la señalización celular o el comportamiento de unión en el laboratorio.
Péptido de migración celular
Esto estudia cómo un péptido influye en la migración de las células hacia un sitio de lesión, de forma similar a los trabajadores que se apresuran a una obra. Se miden la velocidad y el alcance de la migración celular en modelos de laboratorio.
Péptido inmunomodulador
Esto estudia cómo un péptido ajusta la actividad de las células inmunitarias, de forma similar a un regulador que refuerza o atenúa la respuesta inmunitaria. Se miden los recuentos de células inmunitarias y los marcadores de inflamación en los estudios.
What communities discuss
These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.
Anécdotas de cicatrización de heridas
Las personas reportan una curación percibida más rápida de lesiones o problemas de tendones tras usar ciertos péptidos, generalmente sin un grupo de control ni medición objetiva. Estos informes individuales no establecen una eficacia o seguridad reales.
Anécdotas de piel y cabello
Los usuarios intercambian impresiones personales sobre la apariencia de la piel, la profundidad de las arrugas o el crecimiento del cabello tras usar péptidos comercializados cosméticamente, generalmente basándose en sus propias fotos en lugar de dispositivos de medición. Estas impresiones subjetivas y afirmaciones de marketing no son prueba de un efecto confirmado.
Anécdotas de salud intestinal
Las personas reportan mejoras digestivas percibidas subjetivamente tras usar péptidos gastroprotectores o inmunomoduladores, generalmente sin diagnósticos objetivos. Estas autoobservaciones no establecen un efecto confirmado sobre el intestino.
Adverse effects and risk boundaries
- Muchos llamados péptidos reparadores carecen de estudios humanos controlados. Persisten riesgos de efectos sistémicos desconocidos, reacciones inmunes, efectos vasculares o hemorrágicos e infección/contaminación por inyección.
- Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
- A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.
Exclusion groups and professional assessment
- Embarazo, cáncer, infección activa, trastornos de coagulación, cirugía prevista y enfermedades inmunes relevantes exigen valoración especialmente estricta o evitar el uso.
- Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
- Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.
Monitoring and laboratory markers
- No existe un esquema validado de seguimiento para péptidos reparadores no aprobados. Según el caso pueden ser relevantes exploración, inflamación, hemograma, hígado/riñón y coagulación.
- Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.
Evidence boundary
Preclínico
La investigación es mayoritariamente preclínica; el beneficio clínico no está confirmado.
Published evidence
Los datos disponibles provienen principalmente de modelos animales o celulares; faltan datos sólidos de eficacia y seguridad en humanos.
KPV es un fragmento tripeptídico corto de la alfa-MSH, a diferencia de agentes melanocortina más grandes como la afamelanotida.
Storage and stability
- The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
- Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
- Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.
Troubleshooting and error sources
- U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
- Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
- Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
- Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.
Regulatory status and WADA
No aprobado por FDA/EMA
No existe medicamento aprobado por FDA o EMA; eficacia y seguridad no están establecidas.
WADA 2026
The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.
WADA — 2026 Prohibited ListComparisons and related profiles
Combinations / stacks
- Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
- Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
- Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.
Frequently asked questions
Is an amount shown here a recommendation?
No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.
Does the U-100 calculator prove correct use?
No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.
Can this profile be combined with other substances?
Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.
Which source controls when information conflicts?
For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.
Are community claims clinical evidence?
No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.
Sources and evidence layers
Primary sources and official registries take priority. The community reference is labelled separately.
- Primary/technical sourceFDA: 2026 peptide advisory review
- Primary/technical sourceFDA — KPV PCAC briefing document
- Community referenceKPV — Peptide Dosing Protocols